← Back to headlines
KOSDAQ-Listed Bio Firm Under Review for Unfaithful Disclosure
A bio firm listed on the KOSDAQ exchange is set to undergo a review due to unfaithful disclosure practices. This action highlights regulatory scrutiny over corporate transparency in South Korea's stock market.
16 Apr, 02:47 — 16 Apr, 02:47
Sources
Showing 1 of 1 sources
Related Stories
Fed Official Signals Potential September Rate Pause, Cooling Hike Expectations
1h ago
Netherlands Transfers Billions in Gold Reserves From U.S. to London
5h ago
Jet2 Upgrades to London Stock Exchange Main Market After Strong Summer
8h ago
Swiss Economy Hits Five-Year Growth High as Inflation Rises to 0.8 Percent
15h ago